Actual medication pill burden and dosing frequency in HIV-infected patients with undetectable viral loads

Journal of the International Association of Physicians in AIDS Care : JIAPAC
Patrick G Clay

Abstract

Studies have shown equivalent or improved outcomes with once-daily antiretroviral (ARV) regimens, but have failed to quantify the true daily dosing frequency and pill burden of HIV-infected patients, by not considering concomitant medications. This study was conducted to describe the total daily number (pill burden) and dosing frequency for all oral medicines, and not just ARV medications in HIV-infected patients with undetectable viral loads. A retrospective chart review of patients with undetectable viral loads in an HIV primary care clinic identified dosing frequency and pill burden for all prescribed medications. These patients were divided into those with concomitant medications (WITH) and those only on ARV medications (WITHOUT). One hundred and seventeen patients qualified for the evaluation. Ninety-three were in the WITH group and 24 were in the WITHOUT group. WITH patients were older (p < 0.05), and had advanced US Centers for Disease Control and Prevention (CDC)-defined HIV disease stage (p< 0.05), a longer duration of HIV infection (p= 0.03), and a longer duration of AIDS (p= 0.02). WITH patients had a significantly greater total pill burden (p<0.01) and dosing frequency (p<0.001) when considering all medications. Ass...Continue Reading

References

Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Chesney
Jul 21, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·L MoleM Holodniy
Dec 26, 2001·Journal of Clinical Epidemiology·A C JusticeK E Covinsky
Mar 28, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Janis V GiorgiUNKNOWN Multicenter AIDS Cohort Study
Sep 17, 2002·International Journal of STD & AIDS·Loren G MillerRon D Hays
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sanjiv S ShahRobert S Klein
Dec 6, 2002·Drugs·Susan M Cheer, Karen L Goa
Dec 11, 2002·JAMA : the Journal of the American Medical Association·Heather P McDonaldR Brian Haynes
Feb 4, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Maria Paola TrottaUNKNOWN AdICoNA Study Group
Apr 19, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Andrew M PetersonRebecca Finley
May 10, 2003·AIDS Patient Care and STDs·Margaret Chesney
Aug 22, 2003·Journal of the American Academy of Nurse Practitioners·Peter J Piliero, Joseph P Colagreco
Aug 29, 2003·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Calvin CohenUNKNOWN Advisory Committee of the International Association of Physicians in AIDS Care
Nov 11, 2003·Clinical Pharmacokinetics·Anne-Marie TaburetJean-Michel Molina
Dec 19, 2003·Expert Opinion on Investigational Drugs·Pedro Cahn
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Jeffrey M JacobsonWilliam C Olson

❮ Previous
Next ❯

Citations

Jun 7, 2013·Drugs & Aging·E Jennifer EdelmanAmy C Justice

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.